EcoDrugPlus

Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1g-Like

Ensembl ID : ENSPLAG00000022430
Gene Symbol: LOC106938939
2 Cross references
208 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSPLAG00000012673
Gene Symbol: LOC106959052
3 Cross references
167 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSPLAG00000009629
Gene Symbol: LOC106937703
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSPLAG00000012653
Gene Symbol: LOC106959053
3 Cross references
182 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSPLAG00000012696
Gene Symbol: LOC106959060
4 Cross references
184 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSPLAG00000018167
Gene Symbol: LOC106944868
3 Cross references
226 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPLAG00000008793
Gene Symbol: XDH
3 Cross references
208 Possible Orthologues:

Ensembl ID : ENSPLAG00000012782
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSPLAG00000012981
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSPLAG00000017580
Gene Symbol: -
Cross references: -
354 Possible Orthologues:

Ensembl ID : ENSPLAG00000011819
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSPLAG00000011936
Gene Symbol: -
Cross references: -
269 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).